Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0, Supporting ECG Analysis Up to 14 Days

  • ZBeats Inc. obtained FDA 510 clearance for its ZBPro Diagnostic v2.0 software enabling legal use in the U.S. market.
  • The software supports independent ECG analysis for recordings lasting from one minute to 14 days, including Holter monitors and wearable patch data.
  • ZBeats will present the newly cleared ZBPro Diagnostic v2.0 software at HRX Live 2026 in Atlanta, Georgia.
  • Bin Fang, PhD, CEO and co-founder of ZBeats, stated that the clearance advances the company's vision for independent ECG intelligence.
Insights by Ground AI

33 Articles

WFMZWFMZ
+32 Reposted by 32 other sources
Center

ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0, Supporting ECG Analysis Up to 14 Days

Expanded platform supports wearable patches across diverse recording devices; Company to showcase new capabilities at HRX 2026 in Atlanta.

·Pennsylvania, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 78% of the sources are Center
78% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in Chicago, United States on Wednesday, September 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Atlanta, Georgia icon

Atlanta, Georgia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal